Industry News - Tag: Sanofi Consumer Healthcare

You can read Premium News stories in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.

Zantac recall, divestments and regulations curb Sanofi
Premium

8 November 2019

Sanofi's Consumer Healthcare business reported worldwide sales up by 0.4% at constant exchange rates in the third quarter of 2019. The company said growth had been curbed by a voluntary recall of Zantac, non-core brand divestments, and tightening regulatory requirements, particularly in Europe.

Read the full story

Divestments and regulatory action impact Sanofi
Premium

5 August 2019

Sanofi's Consumer Healthcare business reported worldwide sales up by 1.1% at constant exchange rates in the second quarter of 2019. The company said brand divestments and tightening regulatory requirements, particularly in Europe, had reduced growth by around two percentage points.

Read the full story

Emerging Markets keep Sanofi's sales ahead
Premium

29 April 2019

Sanofi's Consumer Healthcare business reported worldwide sales up by 0.6% at constant exchange rates in the first quarter of 2019. The company said growth in the Emerging Markets region had offset lower sales in Developed Markets and the impact of divesting non-core brands.

Read the full story